SEARCH

SEARCH BY CITATION

References

  • 1
    Thompson PW, Kirwan JR, Barnes CG: Practical results of treatment with disease modifying antirheumatoid drugs. Br J Rheumatol 24: 167175, 1985
  • 2
    Kahan BD: Cyclosporin. N Engl J Med 321: 17251738, 1989
  • 3
    van Rijthoven AWAM, Dijkmans BAC, Goei Thè HS, Hermans J, Montnor-Beckers ZLBM, Jacobs PJC, Cats A: Cyclosporin treatment of rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Ann Rheum Dis 45: 726731, 1986
  • 4
    Weinblatt ME, Coblyn JS, Fraser PA, Anderson RJ, Spragg J, Trentham DE, Austen KF: Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum 30: 1117, 1986
  • 5
    Førre ø, Bjerkhoel F, Salvesen CF, Berg KJ, Rugstad HE, Saelid G, Mellbye OJ, Kåss E: An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 30: 8892, 1987
  • 6
    Yocum DE, Klippel JH, Wilder RL, Gerber NL, Austin HA, Wahl SM, Lesko L, Minor JR, Preuss HG, Yarboro C, Berkebile C, Dougherty S: Cyclosporin A in severe, treatment refractory rheumatoid arthritis: a randomized study. Ann Intern Med 109: 863869, 1988
  • 7
    Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhof AV, Kraag GR, Ludwin D, Roberts RS: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 335: 10511055, 1990
  • 8
    Rijthoven van AWAM, Dijkmans BAC, Goei The HS, Meijers KAE, Montnor-Beckers ZLBM, Moolenburgh JD, Boers M, Cats A: Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double-blind study. J Rheumatol 18: 815820, 1991
  • 9
    Dougados M, Awada H, Amor B: Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 47: 127133, 1988
  • 10
    Berg KJ, Førre ø, Bjerkhoel F, Amundsen E, Djoseland O, Rugstad HE, Westre B: Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 29: 11801187, 1986
  • 11
    Dijkmans BAC, van Rijthoven AWAM, Goei The HS, Montnor-Beckers ZLBM, Jacobs PCJ, Cats A: Effect of cyclosporine on serum creatinine in patients with rheumatoid arthritis. Eur J Clin Pharmacol 31: 541545, 1987
  • 12
    Boers M, Rijthoven van AWAM, Goei Thè HS, Dijkmans BAC, Cats A: Serum creatinine levels two years later: follow up of a placebo controlled trial of cyclosporine in rheumatoid patients. Transplant Proc 20 (suppl 4): 371375, 1988
  • 13
    Dougados M, Duchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis. Ann Rheum Dis 48: 550556, 1989
  • 14
    Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35: 729735, 1992
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 16
    le Gallez P, Bird HA, Smith RPS, Greenwood M, Nicol CG, Cox GA, Wright V: A comparison of two dose levels of hydroxychloroquine in rheumatoid arthritis. Br J Clin Pract 41 (suppl 52): 1523, 1987
  • 17
    Pavelka K Jr, Pavelka K Sen, Peliskova Z, Vacha J, Trnavsky K: Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens. Ann Rheum Dis 48: 542546, 1989
  • 18
    Cohen AS, Calkins E: A controlled study of chloroquine as an antirheumatic agent. Arthritis Rheum 1: 297312, 1958
  • 19
    Popert AJ, Meijers KAE, Sharp J, Bier F: Chloroquine diphosphate in rheumatoid arthritis: a controlled trial. Ann Rheum Dis 20: 1835, 1961
  • 20
    Hamilton EBD, Scott JT: Hydroxychloroquine sulfate (“plaquenil”) in treatment of rheumatoid arthritis. Arthritis Rheum 5: 502512, 1962
  • 21
    Mainland D, Sutcliffe MI: Hydroxychloroquine sulphate in rheumatoid arthritis: a six month, double-blind trial. Bull Rheum Dis 13: 287290, 1957
  • 22
    Nuver-Zwart IH, van Riel PLCM, van de Putte LBA, Gribnau FWJ: A double-blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 48: 389395, 1989
  • 23
    Rinehart RE, Rosenbaum EE, Hopkins CE: Chloroquine therapy in rheumatoid arthritis. Northwest Med 56: 703710, 1957
  • 24
    Freedman A, Steinberg VL: Chloroquine in rheumatoid arthritis: a double blindfold trial of treatment for one year. Ann Rheum Dis 19: 243250, 1960
  • 25
    Maksymowych W: Antimalarials in rheumatology: efficacy and safety. Semin Arthritis Rheum 16: 206221, 1987
  • 26
    Nussenblatt RB, Whiting PH, Simpson JG: Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmology 96: 275282, 1983
  • 27
    Salmeron G, Lipsky PE: Immunosuppressive potential of anti-malarials. Am J Med 75: 1924, 1983
  • 28
    Landewé RBM, Miltenburg AMM, Breedveld FC, Daha MR, Dijkmans BAC: Cyclosporine and chloroquine synergistically inhibit the interferon gamma production by CD4 positive and CD8 positive T-cell clones derived from a patient with rheumatoid arthritis. J Rheumatol 19: 13531357, 1992
  • 29
    Frisk-Holmberg M, Bergkvist Y, Domeij-Nyberg B, Hellstrom L, Jansson F: Chloroquine serum concentration and side effects: evidence for dose dependent kinetics. Clin Pharmacol Ther 25: 345350, 1979
  • 30
    Dijkmans BAC, Rijthoven AWAM, van Goei The HS, Boers M, Cats A: Cyclosporine in rheumatoid arthritis, anno 1990 . Semin Arthritis Rheum 22: 3036, 1992